SEP
GILD icon

Southland Equity Partners’s Gilead Sciences GILD Stock Holding History

Southland Equity Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$436K Buy
3,452
+78
+2% +$10.3K 0.08% 186
2026
Q1 		$470K Buy
3,374
+57
+2% +$7.98K 0.09% 155
2025
Q4 		$407K Buy
3,317
+3
+0.1% +$365 0.08% 170
2025
Q3 		$368K Buy
3,314
+29
+0.9% +$3.3K 0.07% 173
2025
Q2 		$364K Buy
3,285
+92
+3% +$9.79K 0.08% 158
2025
Q1 		$358K Buy
3,193
+65
+2% +$6.71K 0.08% 158
2024
Q4 		$289K Buy
3,128
+110
+4% +$9.9K 0.07% 175
2024
Q3 		$253K Buy
3,018
+42
+1% +$3.21K 0.06% 191
2024
Q2 		$204K Buy
+2,976
New +$199K 0.06% 203

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Southland Equity Partners's GILD Position: Q2 2026 in Review

Southland Equity Partners increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $10.3K and bringing the position to 3,452 shares worth $436K. The position accounts for 0.08% of the portfolio, ranked #186.

Southland Equity Partners first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. The position peaked at $470K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Southland Equity Partners held 3,452 shares of Gilead Sciences worth $436K as of Q2 2026.
  • Southland Equity Partners bought 78 Gilead Sciences shares in Q2 2026, an estimated $10.3K.
  • Gilead Sciences made up 0.08% of Southland Equity Partners's portfolio in Q2 2026, its #186 holding.
  • Southland Equity Partners first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
  • Southland Equity Partners's Gilead Sciences position peaked at $470K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.